Home

You can search in the web.

Nanopartículas de sílice para difusión intracelular de agentes bioactivos poco solubles
Marcadores para la selección de terapias personalizadas para el tratamiento del cáncer
Late-Onset Inflammatory Adverse Reactions Related to Soft Tissue Filler Injections
Nanoconjugates Design for the treatment of hormone-dependent tumors
DES-Polyacetal Block Copolymers for the Treatment of Prostate Cancer
A novel delivery platform for camptothecin to cancer cells based in mesoporous silica nanoparticles
Improved Animal Models to Study Tumor Growth and Spontaneous Metastases: Bioluminescence Imaging Characterization of the HT-29 Human Colorectal Cancer Cell Line
Delivery of camptothecin to cancer cells with silica nanoparticles
Nanomedicine at Vall d’Hebron University Hospital
Molecular and Functional Characterization of the Immunoreceptors CD300d and CD300f
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: CADASIL.
A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian population
Pathophysiology of CADASIL disease
CADASIL management or what to do when there is little one can do.
Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progression
Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management
Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1
Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform
Apolipoproteïnes A-I i A-II com a biomarcadors i dianes terapèutiques de les recaigudes post trasplantament de glomeruloesclerosi segmentaria i focal idiopàtica (GESF).
Miguel Aranda Martin